MedPath
NMPA Approval

Triptorelin Acetate Injection

国药准字H20244811

September 3, 2024

Drug Information

醋酸曲普瑞林注射液

注射剂

1ml∶0.1mg(按C₆₄H₈₂N₁₈O₁₃计95.6μg)

化学药品

September 3, 2024

Company Information

Applicant Company

北京市大兴区天华大街5号院3号楼13层1311

Manufacturing Company

北京市大兴区中关村科技园区大兴生物医药产业基地天贵大街16号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

醋酸曲普瑞林注射液 - NMPA 批准文号 | MedPath